The Mitochondrial Biogenesis and Dynamics in Health and Disease Conference

Published on 24/05/2019

19-24 May, 2019

PalmSpring, California, USA

ENYO Pharma will be present at The Mitochondrial Biogenesis and Dynamics in Health and Disease Conference meeting from the 19th to the 24th of May at Palm Spring and presented a poster on the topic: “Chemical targeting of NEET/CISDs proteins reveals the central role of mitochondrial morphodynamics regulation in viral infection”.

https://src.faseb.org/mitochondrial
Poster FASEB 2019

Read next in 'Events'

• The 2024 international workshop on Alport syndrome
• ENYO Pharma annonce un financement de Série C de 39 millions d'euros et l’autorisation de la FDA (IND) pour tester Vonafexor dans un essai clinique de Phase 2 pour les patients atteints du syndrome d'Alport
• 6th CKD Summit – Chronic Kidney Disease Drug Development
• ASN Kidney Week
• Alport Connect 2023, the annual Alport syndrome patient and family meeting in US